Home>>Signaling Pathways>> Neuroscience>> Neuroendocrinology>>Somatorelin (1-44) amide (human) (trifluoroacetate salt)

Somatorelin (1-44) amide (human) (trifluoroacetate salt) (Synonyms: Growth Hormone-releasing Factor (1-44) amide, hpGRF-44, Human Pancreas GRF-44, Somatoliberin)

Catalog No.GC49123

A synthetic GHRH peptide

Products are for research use only. Not for human use. We do not sell to patients.

Somatorelin (1-44) amide (human) (trifluoroacetate salt) Chemical Structure

Cas No.: N/A

Size Price Stock Qty
500 µg
$341.00
In stock
1 mg
$648.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Somatorelin (1-44) amide is a synthetic peptide that corresponds to the full 44-amino acid sequence of growth hormone-releasing hormone (GHRH), a hormone that stimulates the production of growth hormone from the pituitary gland and is involved in the regulation of cell proliferation and differentiation.1,2 Somatorelin induces growth hormone release similarly to GHRH in vitro and in vivo.1

1.Guillemin, R., Brazeau, P., BÖhlen, P., et al.Growth hormone-releasing factor from a human pancreatic tumor that caused acromegalyScience218(4572)585-587(1982) 2.Kiaris, H., Chatzistamou, I., Papavassiliou, A.G., et al.Growth hormone-releasing hormone: Not only a neurohormoneTrends Endocrinol. Metab.22(8)311-317(2011)

Reviews

Review for Somatorelin (1-44) amide (human) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Somatorelin (1-44) amide (human) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.